{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-037254","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2026-08-12T12:29:46+00:00","discovered_at":"2026-08-12T12:35:00.314449+00:00","generated_at":"2026-08-12T12:35:17.102114+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ENvue Medical signs $50M equity facility; amends Series H preferred to add $59M","bullets":["Entered $50M committed equity facility; shares sold at 90% of 3-day VWAP.","40% of net proceeds to redeem Series X Preferred; remainder for working capital.","Second Amendment raises Series H Additional Investment Rights to $59M stated value ($53.1M subscription).","Investor commits to exercise at least $10M in 12 months post-shareholder approval, $833,333.33 monthly minimum.","Exchange cap of 1,858,403 shares (19.99% of outstanding) unless shareholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-037254","json":"https://secwatch.observer/filing/0001493152-26-037254.json","markdown":"https://secwatch.observer/filing/0001493152-26-037254.md","text":"https://secwatch.observer/filing/0001493152-26-037254.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/0001493152-26-037254-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T12:35:17.102114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}